Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC; KLIMB study group.

J Cyst Fibros. 2019 Apr 30. pii: S1569-1993(19)30061-X. doi: 10.1016/j.jcf.2019.03.009. [Epub ahead of print]

2.

Decreased Pseudomonas aeruginosa detection in children after separation of pediatric from adult cystic fibrosis clinics: A single center experience.

Barnes LA, Gaillard PR, Menk JS, Wey AR, Regelmann WE, Demirel N.

Pediatr Pulmonol. 2018 Dec;53(12):1604-1610. doi: 10.1002/ppul.24177. Epub 2018 Oct 23.

PMID:
30353693
3.

Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis.

Mikesell CL, Kempainen RR, Laguna TA, Menk JS, Wey AR, Gaillard PR, Regelmann WE.

Respir Care. 2017 Jul;62(7):920-927. doi: 10.4187/respcare.05349. Epub 2017 Apr 19.

4.

Pulmonary function tests correlated with thoracic volumes in adolescent idiopathic scoliosis.

Ledonio CG, Rosenstein BE, Johnston CE, Regelmann WE, Nuckley DJ, Polly DW Jr.

J Orthop Res. 2017 Jan;35(1):175-182. doi: 10.1002/jor.23304. Epub 2016 Jun 20.

5.

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.

Davies JC, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld M; KIWI Study Group.

Lancet Respir Med. 2016 Feb;4(2):107-15. doi: 10.1016/S2213-2600(15)00545-7. Epub 2016 Jan 21. Erratum in: Lancet Respir Med. 2016 Dec;4(12 ):e57.

6.

Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage.

Cole JB, Dunbar JF, McIntire SA, Regelmann WE, Slusher TM.

Pediatrics. 2015 Mar;135(3):e740-3. doi: 10.1542/peds.2014-2878.

7.

Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.

Schechter MS, Regelmann WE, Sawicki GS, Rasouliyan L, VanDevanter DR, Rosenfeld M, Pasta D, Morgan W, Konstan MW.

Pediatr Pulmonol. 2015 May;50(5):431-40. doi: 10.1002/ppul.23147. Epub 2014 Dec 19.

PMID:
25530325
8.

Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.

McCauley LA, Thomas W, Laguna TA, Regelmann WE, Moran A, Polgreen LE.

Ann Am Thorac Soc. 2014 Feb;11(2):198-204. doi: 10.1513/AnnalsATS.201208-068OC.

9.

Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.

Regelmann WE, Schechter MS, Wagener JS, Morgan WJ, Pasta DJ, Elkin EP, Konstan MW; Investigators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2013 Jul;48(7):649-57. doi: 10.1002/ppul.22658. Epub 2012 Sep 4.

10.

Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.

Wagener JS, Rasouliyan L, VanDevanter DR, Pasta DJ, Regelmann WE, Morgan WJ, Konstan MW; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2013 Jul;48(7):666-73. doi: 10.1002/ppul.22652. Epub 2012 Aug 8.

11.

Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.

Laguna TA, Lin N, Wang Q, Holme B, McNamara J, Regelmann WE.

Pediatr Pulmonol. 2012 Aug;47(8):736-42. doi: 10.1002/ppul.21608. Epub 2012 Jan 3.

12.

Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis.

McColley SA, Ren CL, Schechter MS, Regelmann WE, Pasta DJ, Konstan MW; Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2012 Oct;47(10):966-72. doi: 10.1002/ppul.22519. Epub 2012 Feb 22.

13.

Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis.

Harrison AN, Regelmann WE, Zirbes JM, Milla CE.

Pediatr Pulmonol. 2009 Apr;44(4):330-9. doi: 10.1002/ppul.20994.

PMID:
19274621
14.

The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.

Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, Ren CL.

Pediatr Pulmonol. 2008 Nov;43(11):1117-1123. doi: 10.1002/ppul.20914.

PMID:
18846559
15.

Oral manifestations of a possible new periodic fever syndrome.

Beiraghi S, Myers SL, Regelmann WE, Baker S.

Pediatr Dent. 2007 Jul-Aug;29(4):323-6.

PMID:
17867399
16.

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2007 Aug;151(2):134-9, 139.e1. Epub 2007 Jun 22.

PMID:
17643762
17.

Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.

Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2007 Jun;42(6):513-8.

PMID:
17469151
18.

Staphylococcal alpha-toxin causes increased tracheal epithelial permeability.

Phillips JR, Tripp TJ, Regelmann WE, Schlievert PM, Wangensteen OD.

Pediatr Pulmonol. 2006 Dec;41(12):1146-52.

PMID:
16998922
19.

Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.

Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, Blazar BR, Orchard PJ, Cornfield DN, Grewal SS, Peters C, Regelmann WE, Milla CE, Baker KS.

Biol Blood Marrow Transplant. 2006 Apr;12(4):430-7.

20.

A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?

Regelmann WE.

Clin Infect Dis. 2005 Jun 15;40(12):1745-7. Epub 2005 May 11. No abstract available.

PMID:
15909261
21.

Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.

Garner HP, Phillips JR, Herron JG, Severson SJ, Milla CE, Regelmann WE.

J Lab Clin Med. 2004 Sep;144(3):127-33.

PMID:
15454881
22.

Pulmonary exacerbations in cystic fibrosis.

Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE; Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2004 May;37(5):400-6.

PMID:
15095322
23.

A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis.

McCarty NA, Standaert TA, Teresi M, Tuthill C, Launspach J, Kelley TJ, Milgram LJ, Hilliard KA, Regelmann WE, Weatherly MR, Aitken ML, Konstan MW, Ahrens RC.

Pediatr Pulmonol. 2002 Feb;33(2):90-8.

PMID:
11802244
24.

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada.

Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, Stryker S.

Pediatr Pulmonol. 1999 Oct;28(4):231-41.

PMID:
10497371
25.

Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Shreve MR, Butler S, Kaplowitz HJ, Rabin HR, Stokes D, Light M, Regelmann WE.

J Clin Microbiol. 1999 Mar;37(3):753-7.

26.

Proteinase-free myeloperoxidase increases airway epithelial permeability in a whole trachea model.

Regelmann WE, Schneider LA, Fahrenkrug SC, Gray BH, Johnson S, Herron JM, Clawson CC, Clawson DJ, Wangensteen OD.

Pediatr Pulmonol. 1997 Jul;24(1):29-34.

PMID:
9261850
27.

PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.

Shreve MR, Johnson SJ, Milla CE, Wielinski CL, Regelmann WE.

Am J Respir Crit Care Med. 1997 Mar;155(3):984-9.

PMID:
9117036
28.

Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig.

Brottman GM, Regelmann WE, Slungaard A, Wangensteen OD.

Pediatr Pulmonol. 1996 Mar;21(3):159-66.

PMID:
8860070
29.
30.

Delivery of oxygen to children with lower respiratory tract infection.

Regelmann WE.

J Pediatr. 1995 Sep;127(3):427-8. No abstract available.

PMID:
7658274
31.

Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis.

Regelmann WE, Siefferman CM, Herron JM, Elliott GR, Clawson CC, Gray BH.

Pediatr Pulmonol. 1995 Jan;19(1):1-9.

PMID:
7675551
32.

Diagnosing the cause of recurrent and persistent pneumonia in children.

Regelmann WE.

Pediatr Ann. 1993 Sep;22(9):561-8. Review.

PMID:
8108169
33.
34.

Resolution of severe intrapulmonary shunting after liver transplantation.

Schwarzenberg SJ, Freese DK, Regelmann WE, Gores PF, Boudreau RJ, Payne WD.

Chest. 1993 Apr;103(4):1271-3.

PMID:
8131482
35.

Comparison of Tc-99m DTPA aerosol ventilation studies with pulmonary function testing in cystic fibrosis.

Kuni CC, Budd JR, Regelmann WE, Ducret RP, Boudreau RJ.

Clin Nucl Med. 1993 Jan;18(1):15-8.

PMID:
8422713
36.

Aerosol scintigraphy in the assessment of therapy for cystic fibrosis.

Kuni CC, Regelmann WE, duCret RP, Boudreau RJ, Budd JR.

Clin Nucl Med. 1992 Feb;17(2):90-3.

PMID:
1563189
37.

The association of pauciarticular juvenile arthritis and myasthenia gravis.

Glass JB, Sher PK, Lennon VA, Regelmann WE.

Am J Dis Child. 1991 Oct;145(10):1176-80.

PMID:
1928013
38.

Increased monocyte oxidase activity in cystic fibrosis heterozygotes and homozygotes.

Regelmann WE, Skubitz KM, Herron JM.

Am J Respir Cell Mol Biol. 1991 Jul;5(1):27-33.

PMID:
1652266
40.
41.

Lyme disease in children.

Belani K, Regelmann WE.

Rheum Dis Clin North Am. 1989 Nov;15(4):679-90. Review.

PMID:
2685925
42.

Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells.

Miller LC, Gray ED, Mansour M, Abdin ZH, Kamel R, Zaher S, Regelmann WE.

J Rheumatol. 1989 Nov;16(11):1436-42.

PMID:
2600943
43.

Distribution of cells bearing "rheumatic" antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease.

Regelmann WE, Talbot R, Cairns L, Martin D, Miller LC, Zabriskie JB, Braun D, Gray ED.

J Rheumatol. 1989 Jul;16(7):931-5.

PMID:
2475627
44.

Augmentation of cytotoxic activity by mitogens in rheumatic heart disease.

Gray ED, Abdin ZH, el Kholy A, Mansour M, Miller LC, Zaher S, Kamel R, Regelmann WE.

J Rheumatol. 1988 Nov;15(11):1672-6.

PMID:
2976830
45.

Cell surface markers and cellular immune response associated with rheumatic heart disease: complex segregation analysis.

Rich SS, Gray ED, Talbot R, Martin D, Cairns L, Zabriskie JB, Braun D, Regelmann WE.

Genet Epidemiol. 1988;5(6):463-70.

PMID:
3209057
47.

Compartmentalization of cells bearing "rheumatic" cell surface antigens in peripheral blood and tonsils in rheumatic heart disease.

Gray ED, Regelmann WE, Abdin Z, el Kholy A, Zaher S, Kamel R, Mansour M, Miller L, Ferrieri P, Zabriskie JB, et al.

J Infect Dis. 1987 Feb;155(2):247-52.

PMID:
3805764
48.

Lymphocyte subpopulations in rheumatic heart disease.

Regelmann WE, Gray ED, Wannamaker LW, Lebien TW, Mansour M, el Kholy A, Abdin Z.

J Rheumatol. 1987 Feb;14(1):23-7.

PMID:
2952796
49.

Interference with granulocyte function by Staphylococcus epidermidis slime.

Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG.

Infect Immun. 1986 Oct;54(1):13-20.

50.

Aerosol penetration ratio: a new index of ventilation.

Sirr SA, Elliott GR, Regelmann WE, Juenemann PJ, Morin RL, Boudreau RJ, Warwick WJ, Loken MK.

J Nucl Med. 1986 Aug;27(8):1343-6.

Supplemental Content

Loading ...
Support Center